Tevogen Bio Holdings Inc. (TVGN)

NASDAQ: TVGN · IEX Real-Time Price · USD

0.798

+0.019 (2.44%)

At close: Jul 19, 2024, 4:00 PM

0.831

+0.033 (4.14%)

Pre-market: Jul 22, 2024, 8:00 AM EDT

Tevogen Bio Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-51.21	-60.48	-22.04	-15.6
Depreciation & Amortization	0.48	0.38	0.23	0.01
Share-Based Compensation	26.33	0	4.58	0.58
Other Operating Activities	14.14	51.93	8.58	9.73
Operating Cash Flow	-10.26	-8.17	-8.66	-5.27
Capital Expenditures	-0.13	-0.13	-0.48	-0.11
Change in Investments	-333.27	0	0	0
Investing Cash Flow	-333.4	-0.13	-0.48	-0.11
Share Issuance / Repurchase	0.23	0	0	0
Debt Issued / Paid	4	4	7.5	12.5
Other Financing Activities	335.34	-0.13	-	-
Financing Cash Flow	339.57	3.87	7.5	12.5
Net Cash Flow	-4.09	-4.43	-1.63	7.12
Free Cash Flow	-10.39	-8.3	-9.13	-5.38
Free Cash Flow Per Share	-0.08	-0.34	-0.36	-0.21

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).